No abstract

The focus of this study is to understand the multiconfigurational nature of the biradical species involved in the early reaction paths of the oxygen plus ethylene PES. In previous work (J Phys Chem A 113, 12663, 2009), the lowest-lying O( 3 P) ? C 2 H 4 PES was extensively explored at the MCSCF, MRMP2, and MR-AQCC levels of theory. In the current work, ground and excited, triplet-and singlet-state reaction paths for the initial addition of oxygen to ethylene were found at the MCSCF and MRMP2 levels along with five singlet pathways near the Á CH 2 CH 2 O Á biradical at the MCSCF, MRMP2, and CR-CC(2,3) levels. One of these five paths can lead to the CH 2 CO ? H 2 products from CH 3 CHO rather than from the Á CH 2 CH 2 O Á biradical, and this pathway was investigated with a variety of CAS sizes. To provide further comparison between the MRMP2 and CR-CC(2,3) levels, MR-AQCC single-point energies and optimizations were performed for select geometries. After the initial exploration of this region of the surface, the lowest singlettriplet surface crossings were explicitly determined at the MCSCF level. Additional MRMP2 calculations were performed to demonstrate the limitations of single-state perturbation theory in this biradical region of the PES, and SO-MCQDPT2 single-point energies using SA MCSCF were calculated on a grid of geometries around the primary surface crossing. In particular, these calculations were examined to determine a proper active space and a physically reasonable number of electronic states. The results of this examination show that at least four states must be considered to represent this very complex region of the PES.

Right ventricular metastases from renal cell carcinoma without inferior vena cava (IVC) or right atrium involvement are rare. We discuss a 44-year-old male who presented with a left thigh mass, which was resected and the pathology revealed an epithelial sarcoma or a possible metastasis from another organ. His preradiotherapy cardiac evaluation showed mass in the right and left ventricles, which was confirmed by transesophagial echocardiogram. Computed tomography revealed a right renal mass in addition to the ventricular masses without any involvement of IVC or the atria. The patient underwent right radical nephrectomy without complications and systemic chemotherapy with interleukin-1 for metastatic renal cell carcinoma. He is doing well and follow-up echocardiogram showed significant reduction in the size of the cardiac metastases, even without surgical resection of these tumors. Thus, our article presents this unique case of asymptomatic ventricular metastases of renal cell carcinoma without any atrial or caval involvement and provides a new insight into the management of this syndrome.

No abstract

No abstract